Skip to main content
Fig. 1 | EJNMMI Research

Fig. 1

From: Repeatability of quantitative parameters of 18F-fluoride PET/CT and biochemical tumour and specific bone remodelling markers in prostate cancer bone metastases

Fig. 1

Patient 8 at baseline (a) and at +7 days (b) performing PET1 and PET2. Five chosen index lesions (numbered 1–5) were delineated for VOI measuring SUVmax, SUVmean, FTV50% and total lesion fluoride uptake at PET/CT (baseline). c Included lesions are highlighted in red (n = 17) and the blue uptake represents lesions that were omitted, urine activity and degenerative or equivocal findings

Back to article page